Literature DB >> 33925004

Host Cell Restriction Factors of Bunyaviruses and Viral Countermeasures.

Solène Lerolle1, Natalia Freitas1, François-Loïc Cosset1, Vincent Legros1,2.   

Abstract

The Bunyavirales order comprises more than 500 viruses (generally defined as bunyaviruses) classified into 12 families. Some of these are highly pathogenic viruses infecting different hosts, including humans, mammals, reptiles, arthropods, birds, and/or plants. Host cell sensing of infection activates the innate immune system that aims at inhibiting viral replication and propagation. Upon recognition of pathogen-associated molecular patterns (PAMPs) by cellular pattern recognition receptors (PRRs), numerous signaling cascades are activated, leading to the production of interferons (IFNs). IFNs act in an autocrine and paracrine manner to establish an antiviral state by inducing the expression of hundreds of IFN-stimulated genes (ISGs). Some of these ISGs are known to restrict bunyavirus infection. Along with other constitutively expressed host cellular factors with antiviral activity, these proteins (hereafter referred to as "restriction factors") target different steps of the viral cycle, including viral entry, genome transcription and replication, and virion egress. In reaction to this, bunyaviruses have developed strategies to circumvent this antiviral response, by avoiding cellular recognition of PAMPs, inhibiting IFN production or interfering with the IFN-mediated response. Herein, we review the current knowledge on host cellular factors that were shown to restrict infections by bunyaviruses. Moreover, we focus on the strategies developed by bunyaviruses in order to escape the antiviral state developed by the infected cells.

Entities:  

Keywords:  bunyaviruses; innate immunity; interferon; restriction factors; viral countermeasures

Year:  2021        PMID: 33925004     DOI: 10.3390/v13050784

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  204 in total

1.  The Andes Orthohantavirus NSs Protein Antagonizes the Type I Interferon Response by Inhibiting MAVS Signaling.

Authors:  Jorge Vera-Otarola; Loretto Solis; Fernando Lowy; Valeria Olguín; Jenniffer Angulo; Karla Pino; Nicole D Tischler; Carola Otth; Paula Padula; Marcelo López-Lastra
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

2.  A genome-wide RNAi screen reveals that mRNA decapping restricts bunyaviral replication by limiting the pools of Dcp2-accessible targets for cap-snatching.

Authors:  Kaycie C Hopkins; Laura M McLane; Tariq Maqbool; Debasis Panda; Beth Gordesky-Gold; Sara Cherry
Journal:  Genes Dev       Date:  2013-07-01       Impact factor: 11.361

3.  Plasmacytoid dendritic cells are productively infected and activated through TLR-7 early after arenavirus infection.

Authors:  Mónica Macal; Gavin M Lewis; Stefan Kunz; Richard Flavell; James A Harker; Elina I Zúñiga
Journal:  Cell Host Microbe       Date:  2012-06-14       Impact factor: 21.023

4.  Interferon-induced rat Mx proteins confer resistance to Rift Valley fever virus and other arthropod-borne viruses.

Authors:  M Sandrock; M Frese; O Haller; G Kochs
Journal:  J Interferon Cytokine Res       Date:  2001-09       Impact factor: 2.607

5.  Toscana virus NSs protein promotes degradation of double-stranded RNA-dependent protein kinase.

Authors:  Birte Kalveram; Tetsuro Ikegami
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

6.  NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase.

Authors:  Matthias Habjan; Andreas Pichlmair; Richard M Elliott; Anna K Overby; Timo Glatter; Matthias Gstaiger; Giulio Superti-Furga; Hermann Unger; Friedemann Weber
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

7.  Effects of allelic variations in the human myxovirus resistance protein A on its antiviral activity.

Authors:  Laura Graf; Alexej Dick; Franziska Sendker; Emanuel Barth; Manja Marz; Oliver Daumke; Georg Kochs
Journal:  J Biol Chem       Date:  2018-01-12       Impact factor: 5.157

8.  A diverse range of gene products are effectors of the type I interferon antiviral response.

Authors:  John W Schoggins; Sam J Wilson; Maryline Panis; Mary Y Murphy; Christopher T Jones; Paul Bieniasz; Charles M Rice
Journal:  Nature       Date:  2011-04-10       Impact factor: 49.962

9.  Differential recognition of double-stranded RNA by RIG-I-like receptors in antiviral immunity.

Authors:  Takeshi Saito; Michael Gale
Journal:  J Exp Med       Date:  2008-07-07       Impact factor: 14.307

Review 10.  Interferon-inducible antiviral effectors.

Authors:  Anthony J Sadler; Bryan R G Williams
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

View more
  3 in total

1.  NSG-Mice Reveal the Importance of a Functional Innate and Adaptive Immune Response to Overcome RVFV Infection.

Authors:  Lukas Mathias Michaely; Melanie Rissmann; Markus Keller; Rebecca König; Felicitas von Arnim; Martin Eiden; Karl Rohn; Wolfgang Baumgärtner; Martin Groschup; Reiner Ulrich
Journal:  Viruses       Date:  2022-02-08       Impact factor: 5.048

2.  Epidemiological study of Kabuto Mountain virus, a novel uukuvirus, in Japan.

Authors:  Ngo T B Tran; Hiroshi Shimoda; Junko Mizuno; Keita Ishijima; Kenzo Yonemitsu; Shohei Minami; Yudai Kuroda; Kango Tatemoto; Milagros V Mendoza; Ai Takano; Masahiko Muto; Haruhiko Isawa; Kyoko Sawabe; Daisuke Hayasaka; Ken Maeda
Journal:  J Vet Med Sci       Date:  2021-12-11       Impact factor: 1.267

Review 3.  The Emerging Role of the Serine Incorporator Protein Family in Regulating Viral Infection.

Authors:  Shaofen Xu; Zhichao Zheng; Janak L Pathak; Haoyu Cheng; Ziliang Zhou; Yanping Chen; Qiuyu Wu; Lijing Wang; Mingtao Zeng; Lihong Wu
Journal:  Front Cell Dev Biol       Date:  2022-04-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.